Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy

BMC Nephrology

Takamune Takahashi¹  Christopher C Quarles⁴  Raymond C Harris¹  Hiroki Fujita³  Chuan-Ming Hao⁴  Dana Zemel⁴  Todd E Peterson²  Keiko Takahashi⁴  Feng Wang⁴  Rosie Jiang⁴  Mohammed N Tantawy⁴ 

[1] Division of Nephrology and Hypertension, Vanderbilt University School of Medicine, S-3223, MCN, Nashville, TN, 37232, USA;Radiology and Vanderbilt University Institute of Imaging Science, Nashville, TN, USA;Division of Endocrinology, Metabolism and Geriatric Medicine, Akita University Graduate School of Medicine, Akita, Japan;Vanderbilt O'Brien Mouse Kidney Physiology and Disease Center, Vanderbilt University Medical Center, Nashville, TN, USA

关键词: Renal function;    Unilateral ureteral obstruction;    Mouse model;    ^99mTc-MAG3;    Renal scintigraphy;    Nuclear imaging;   

Others  :  1083044
DOI  :  10.1186/1471-2369-13-168

 received in 2012-06-14, accepted in 2012-11-27,  发布年份 2012

【 摘 要 】

Background

Renal scintigraphy using ^99mTc-mercaptoacetyltriglycine (^99mTc-MAG3) is widely used for the assessment of renal function in humans. However, the application of this method to animal models of renal disease is currently limited, especially in rodents. Here, we have applied ^99mTc-MAG3 renal scintigraphy to a mouse model of unilateral ureteral obstruction (UUO) and evaluated its utility in studying obstructive renal disease.

Methods

UUO mice were generated by complete ligation of the left ureter. Sham-operated mice were used as a control. Renal function was investigated on days 0, 1, 3, and 6 post-surgery using dynamic planar imaging of ^99mTc-MAG3 activity following retro-orbital injection. Time-activity curves (TACs) were produced for individual kidneys and renal function was assessed by 1) the slope of initial ^99mTc-MAG3 uptake (SIU), which is related to renal perfusion; 2) peak activity; and 3) the time-to-peak (TTP). The parameters of tubular excretion were not evaluated in this study as ^99mTc-MAG3 is not excreted from UUO kidneys.

Results

Compared to sham-operated mice, SIU was remarkably (>60%) reduced in UUO kidneys at day 1 post surgery and the TACs plateaued, indicating that ^99mTc-MAG3 is not excreted in these kidneys. The plateau activity in UUO kidneys was relatively low (~40% of sham kidney’s peak activity) as early as day1 post surgery, demonstrating that uptake of ^99mTc-MAG3 is rapidly reduced in UUO kidneys. The time to plateau in UUO kidneys exceeded 200 sec, suggesting that ^99mTc-MAG3 is slowly up-taken in these kidneys. These changes advanced as the disease progressed. SIU, peak activity and TTPs were minimally changed in contra-lateral kidneys during the study period.

Conclusions

Our data demonstrate that renal uptake of ^99mTc-MAG3 is remarkably and rapidly reduced in UUO kidneys, while the changes are minimal in contra-lateral kidneys. The parametric analysis of TACs suggested that renal perfusion as well as tubular uptake is reduced in UUO kidneys. This imaging technique should allow non-invasive assessments of UUO renal injury and enable a more rapid interrogation of novel therapeutic agents and protocols.

【 授权许可】

   
2012 Tantawy et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Itoh K: 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function. Ann Nucl Med 2001, 15(3):179-190.
• [2]Fritzberg AR, Kasina S, Eshima D, Johnson DL: Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med 1986, 27(1):111-116.
• [3]Gates GF: Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine. Clin Nucl Med 2004, 29(4):231-237.
• [4]Esteves FP, Taylor A, Manatunga A, Folks RD, Krishnan M, Garcia EV: 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume. AJR Am J Roentgenol 2006, 187(6):W610-W617.
• [5]Roberts J, Chen B, Curtis LM, Agarwal A, Sanders PW, Zinn KR: Detection of early changes in renal function using 99mTc-MAG3 imaging in a murine model of ischemia-reperfusion injury. Am J of Physiol Renal Physiol 2007, 293(4):F1408-F1412.
• [6]Herrler T, Tischer A, Meyer A, Feiler S, Guba M, Nowak S, Rentsch M, Bartenstein P, Hacker M, Jauch KW: The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation 2010, 89(1):40-46.
• [7]Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al.: Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008, 51(Suppl 1):A6-A7.
• [8]Chevalier RL, Thornhill BA, Forbes MS, Kiley SC: Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 2010, 25(4):687-697.
• [9]Eddy AA, Lopez-Guisa JM, Okamura DM, Yamaguchi I: Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol 2012, 27(8):1233-1247.
• [10]Chevalier RL, Forbes MS, Thornhill BA: Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009, 75(11):1145-1152.
• [11]Ayala JE, Bracy DP, Malabanan C, James FD, Ansari T, Fueger PT, McGuinness OP, Wasserman DH: Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp 2011, 57:e3188.
• [12]Loening AM, Gambhir SS: AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003, 2(3):131-137.
• [13]Mustafa S, Elgazzar AH, Essam H, Gopinath S, Mathew M: Hyperthermia alters kidney function and renal scintigraphy. Am J Nephrol 2007, 27(3):315-321.
• [14]Nanni C, Pettinato C, Ambrosini V, Spinelli A, Trespidi S, Rubello D, Al-Nahhas A, Franchi R, Alavi A, Fanti S: Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nucl Med Commun 2007, 28(7):547-553.
• [15]Moody TE, Vaughn ED Jr, Gillenwater JY: Relationship between renal blood flow and ureteral pressure during 18 hours of total unilateral uretheral occlusion. Implications for changing sites of increased renal resistance. Invest Urol 1975, 13(3):246-251.
• [16]Vaughan ED Jr, Marion D, Poppas DP, Felsen D: Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol 2004, 172:2563-2569.
• [17]Yeh CH, Chiang HS, Lai TY, Chien CT: Unilateral ureteral obstruction evokes renal tubular apoptosis via the enhanced oxidative stress and endoplasmic reticulum stress in the rat. Neurourol Urodyn 2011, 30(3):472-479.
• [18]Kahn SA, Gulmi FA, Chou SY, Mooppan UM, Kim H: Contribution of endothelin-1 to renal vasoconstriction in unilateral ureteral obstruction: reversal by verapamil. J Urol 1997, 157(5):1957-1962.
• [19]Bhangdia DK, Gulmi FA, Chou SY, Mooppan UM, Kim H: Alterations of renal hemodynamics in unilateral ureteral obstruction mediated by activation of endothelin receptor subtypes. J Urol 2003, 170(5):2057-2062.
• [20]Sigmon DH, Gonzalez-Feldman E, Cavasin MA, Potter DL, Beierwaltes WH: Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 2004, 15(6):1413-1420.
• [21]Valdivielso JM, Perez-Barriocanal F, Garcia-Estan J, Lopez-Novoa JM: Role of nitric oxide in the early renal hemodynamic response after unilateral nephrectomy. Am J Physiol 1999, 276:R1718-R1723.
• [22]Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002, 283(5):F861-F875.
• [23]Hegarty NJ, Young LS, Kirwan CN, O'Neill AJ, Bouchier-Hayes DM, Sweeney P, Watson RW, Fitzpatrick JM: Nitric oxide in unilateral ureteral obstruction: effect on regional renal blood flow. Kidney Int 2001, 59(3):1059-1065.
• [24]Topcu SO, Celik S, Erturhan S, Erbagci A, Yagci F, Ucak R: Verapamil prevents the apoptotic and hemodynamic changes in response to unilateral ureteral obstruction. Int J Urol 2008, 15(4):350-355.
• [25]Schlotmann A, Clorius JH, Rohrschneider WK, Clorius SN, Amelung F, Becker K: Diuretic renography in hydronephrosis: delayed tissue tracer transit accompanies both functional decline and tissue reorganization. J Nucl Med 2008, 49(7):1196-1203.
• [26]Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolcay S, Cansiz T, Kapicioglu T, Urgancioglu I: Technetium-99m-N, N-ethylenedicysteine–a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease. J Nucl Med 1994, 35(5):840-845.
• [27]Coffey J: Flow rate models in renal obstruction. World J Urol 2010, 29(1):109-114.